Regulation of Dendritic Cell Migration to the Draining Lymph Node
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Antigen-pulsed dendritic cells (DCs) are used as natural adjuvants for vaccination, but the factors that influence the efficacy of this treatment are poorly understood. We investigated the parameters that affect the migration of subcutaneously injected mouse-mature DCs to the draining lymph node. We found that the efficiency of DC migration varied with the number of injected DCs and that CCR7+/+ DCs migrating to the draining lymph node, but not CCR7-/- DCs that failed to do so, efficiently induced a rapid increase in lymph node cellularity, which was observed before the onset of T cell proliferation. We also report that DC migration could be increased up to 10-fold by preinjection of inflammatory cytokines that increased the expression of the CCR7 ligand CCL21 in lymphatic endothelial cells. The magnitude and quality of CD4+ T cell response was proportional to the number of antigen-carrying DCs that reached the lymph node and could be boosted up to 40-fold by preinjection of tumor necrosis factor that conditioned the tissue for increased DC migration. These results indicate that DC number and tissue inflammation are critical parameters for DC-based vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mouse DCs start to enter the regional lymph node 18 hours after inoculation in the skin, reaching a maximum within 72 hours.50,51”
From Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells (2006) · cites this paper as [50]
Experimental — accuracy not yet measuredIn the citing paper
“besides their critical role for priming T cells in lymph nodes (Martin-Fontecha et al., 2003)”
From Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12 (2018) · cites this paper as Martin-Fontecha et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336 · cited 1×
“Tissue-resident DCs and DC precursors, such as monocytes or immature DCs recruited from the blood, are stimulated by microbial products and inflammatory cytokines to undergo a coordinately regulated process of maturation and migration (1).”
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410 · cited 1×
“The finding that DC migration can be boosted by inflammatory stimuli through up-regulation of CCL21 on lymphatic endothelial cells was unexpected, because CCL21 has been considered the prototype of constitutive chemokines (27).”
Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Müller, I., Wolf, E., & Lipp, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80059-8 · Cited by 2,367 · cited 5×
“Lack of CCR7 or its ligands leads to dramatic changes in DC and lymphocyte traffic and abnormal lymph node architecture (8, 9).”
InfluentialSelf-citationAlteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690 · cited 5×
“The fact that CCR7 / DCs, which are incapable of migrating to the lymph node, do not cause lymph node congestion indicates that this phenomenon is mediated by mature DCs that have reached the lymph node through mechanisms that still need to be identified but might be related to release of chemokines or S1P.”
InfluentialDieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., & Caux, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.373 · Cited by 1,425 · cited 1×
“Immature DCs express receptors for inflammatory chemokines and, upon induction of maturation, up-regulate CCR7, a chemokine receptor that drives their migration to the lymphatics (2, 3).”
Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021598 · Cited by 1,306
Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., & Lanzavecchia, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09<2760::aid-immu2760>3.0.co;2-n · Cited by 1,183 · cited 1×
“Immature DCs express receptors for inflammatory chemokines and, upon induction of maturation, up-regulate CCR7, a chemokine receptor that drives their migration to the lymphatics (2, 3).”
Gunn, M. D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T., & Nakano, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.451 · Cited by 1,019 · cited 2×
“In plt/plt mice, which carry a spontaneous mutation that abolishes CCL19 expression and restricts CCL21 expression to the lymphatic endothelium, DCs and naive T cells fail to enter the T cell zone of secondary lymphoid organs (9, 10).”
Gunn, M. D., Tangemann, K., Tam, C., Cyster, J. G., Rosen, S. D., & Williams, L. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.258 · Cited by 1,001
Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.239 · Cited by 706
Cited by
Items 301–400 of 888
The pathogenic importance of CCL21 and CCR7 in rheumatoid arthritis
Raemdonck, K. V., Umar, S., & Shahrara, S. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.007 · Cited by 54
Kimber, I., Maxwell, G., Gilmour, N., Dearman, R. J., Friedmann, P. S., & Martin, S. F. (2011) · Toxicology · doi:10.1016/j.tox.2011.11.007 · Cited by 51
Beauchamp, N. M., Busick, R. Y., & Alexander‐Miller, M. A. (2010) · Journal of Virology · doi:10.1128/jvi.00892-10 · Cited by 51
Lymphatic immunomodulation using engineered drug delivery systems for cancer immunotherapy
Manspeaker, M. P., & Thomas, S. N. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.004 · Cited by 52
The C-Type Lectin Macrophage Galactose-Type Lectin Impedes Migration of Immature APCs
van Vliet, S. J., Paessens, L. C., van den Berg, V. C. M., Geijtenbeek, T. B. H., & van Kooyk, Y. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3148 · Cited by 51
Ciabattini, A., Pettini, E., Fiorino, F., Prota, G., Pozzi, G., & Medaglini, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019346 · Cited by 50
The role of core TNF/LIGHT family members in lymph node homeostasis and remodeling
Zhu, M., & Fu, Y. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01061.x · Cited by 50
“(6) found that the magnitude and quality of the CD4 T-cell response is proportional to the number of antigen-carrying DCs that reached the lymph node.”
BackgroundQu, Y., Rose, R. D., Kim, C., Zhou, J., Lin, Z., Ju, Y., Bhangu, S. K., Cortez‐Jugo, C., Cavalieri, F., & Caruso, F. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202214935 · Cited by 49
Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging
Dekaban, G. A., Hamilton, A. M., Fink, C., Au, B., de Chickera, S. N., Ribot, E. J., & Foster, P. J. (2013) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1227 · Cited by 55
Fink, C., Gaudet, J. M., Fox, M. S., Bhatt, S., Viswanathan, S., Smith, M. H., Chin, J. L., Foster, P. J., & Dekaban, G. A. (2018) · Scientific Reports · doi:10.1038/s41598-017-19031-0 · Cited by 52
Shahgordi, S., Sankian, M., Yazdani, Y., Mashayekhi, K., Ayati, S. H., Sadeghi, M., Saeidi, M., & Hashemi, M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106525 · Cited by 49
Ahmadi, T., Flies, A., Efebera, Y. A., & Sherr, D. H. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02749.x · Cited by 49
Intermediate maturation of Mycobacterium tuberculosis LAM-activated human dendritic cells
Dulphy, N., Herrmann, J., Nigou, J., Réa, D., Boissel, N., Puzo, G., Charron, D. J., Lagrange, P. H., & Toubert, A. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00881.x · Cited by 49
“DCs, depending on their maturation status, influence the quality and the magnitude of the T-cell response (Martin-Fontecha et al., 2003).”
BackgroundInteraction of Polysialic Acid with CCL21 Regulates the Migratory Capacity of Human Dendritic Cells
Bax, M., van Vliet, S. J., Litjens, M., García-Vallejo, J. J., & van Kooyk, Y. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006987 · Cited by 45
“Migration of DCs from the periphery to the lymph node is regulated by the expression of CCL21 in the secondary lymphoid organs and its receptor CCR7expressed by mDCs [14].”
BackgroundInfluentialPei, W., Wan, X., Shahzad, K. A., Zhang, L., Song, S., Jin, X., Wang, L., Zhao, C., & Shen, C. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s164500 · Cited by 48
“Similarly, DCs, spleen cells or peripheral blood cells carrying myelin protein or peptides along with other modulators have been reported to work as tolerogenic antigen-presenting cells (APCs) and induce immune tolerance in MS or EAE, but are limited by the high cost, inadequate cell numbers and safety issues due to t…”
Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma
Sperveslage, J., Frank, S., Heneweer, C., Egberts, J. H., Schniewind, B., Buchholz, M., Bergmann, F., Giese, N. A., Munding, J. B., Hahn, S. A., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26502 · Cited by 48
“Recent data suggest that factors produced by activated dendritic cells or treatment with proinflammatory cytokines such as TNF-alpha and oncostatin M enhance CCL21 expression in lymphatic vessels.(23,24) CCL21 expression therefore appears to be inflammation associated and cytokine regulated.”
BackgroundCCR7 Signaling Inhibits T Cell Proliferation
Ziegler, E., Oberbarnscheidt, M. H., Bulfone‐Paus, S., Förster, R., Kunzendorf, U., & Krautwald, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6485 · Cited by 57
“Furthermore, CCR7 is also important in mediating colocalization and, thus, Ag-specific T cell activation (4, 5).”
BackgroundScavenging of soluble and immobilized CCL21 by ACKR4 regulates peripheral dendritic cell emigration
Bastow, C. R., Bunting, M. D., Kara, E. E., McKenzie, D. R., Caon, A., Devi, S., Tolley, L., Mueller, S. N., Frazer, I. H., Harvey, N., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025763118 · Cited by 47
Ectopic Activation of Mycobacterium tuberculosis -Specific CD4+ T Cells in Lungs of CCR7−/− Mice
Olmos, S., Stukes, S. A., & Ernst, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901230 · Cited by 54
Myeloid Populations in Systemic Autoimmune Diseases
Morell, M. H., Varela, N., & Marañón, C. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8606-7 · Cited by 50
Schjenken, J. E., Moldenhauer, L. M., Zhang, B., Care, A. S., Groome, H. M., Chan, H. Y., Hope, C. M., Barry, S. C., & Robertson, S. A. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0255-0 · Cited by 50
Resik, S., Tejeda, A., Mach, O., Sein, C., Molodecky, N. A., Jarrahian, C., Saganic, L., Zehrung, D., Fonseca, M. C., Díaz, M., et al. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.071 · Cited by 47
Yoneyama, H., Matsuno, K., & Matsushima, K. (2005) · International Journal of Hematology · doi:10.1532/ijh97.04164 · Cited by 47
“Local TNF-� accelerates mDC precursor influx via CCL3 as well as efflux via CCL21 [ 37 ].”
BackgroundSublingual immunotherapy: The optimism and the issues
Pajno, G. B. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.01.009 · Cited by 49
Flacher, V., Sparber, F., Tripp, C. H., Romani, N., & Stoitzner, P. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0563-9 · Cited by 47
“A recent report demonstrated that the migration of injected dendritic cells can be improved by conditioning the injection site with either dendritic cells or proinXammatory cytokines like TNF- [29].”
BackgroundEffects of TCDD on the Fate of Naive Dendritic Cells
Bankoti, J., Burnett, A., Navarro, S., Miller, A. K., Rase, B., & Shepherd, D. M. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq063 · Cited by 49
Cellular Immunotherapy with Dendritic Cells in Cancer: Current Status
Nencioni, A., & Brossart, P. (2004) · Stem Cells · doi:10.1634/stemcells.22-4-501 · Cited by 54
Semiquantitation of Mouse Dendritic Cell Migration In Vivo Using Cellular MRI
Dekaban, G. A., Snir, J. A., Shrum, B., de Chickera, S., Willert, C., Merrill, M., Said, E. A., Sékaly, R., Foster, P. J., & O’Connell, P. J. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318197b2a0 · Cited by 48
Cancer vaccines for established cancer: how to make them better?
Andrews, D. M., Maraskovsky, E., & Smyth, M. J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00612.x · Cited by 47
“draining LN following footpad injection (79).”
BackgroundInfluentialNakamoto, Y., Mizukoshi, E., Tsuji, H., Sakai, Y., Kitahara, M., Kazumori, A. R. A. I., Yamashita, T., Yokoyama, K., Mukaida, N., Matsushima, K., et al. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03290.x · Cited by 50
Mori, M., Andersson, C. K., Graham, G. J., Löfdahl, C., & Erjefalt, J. S. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-65 · Cited by 48
“Among the major cells expressing the receptor for CCL21 are antigen-activated dendritic cells [20,37].”
BackgroundEmerging immunotherapies for glioblastoma
Desai, R. R., Suryadevara, C. M., Batich, K. A., Farber, S. H., Sanchez-Perez, L. A., & Sampson, J. H. (2016) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2016.1186643 · Cited by 49
“[54,55] A seminal preclinical study revealed that preconditioning the vaccine site with inflammatory cytokines or mature, unpulsed DCs significantly increases the migration of subsequently injected antigen-specific DCs to draining LNs, which then proportionally increases the magnitude and quality of induced T-cell res…”
BackgroundLeón, B., & Lund, F. E. (2019) · Immunological Reviews · doi:10.1111/imr.12758 · Cited by 49
Pfirschke, C., Žilionis, R., Engblom, C., Messemaker, M., Zou, A. E., Rickelt, S., Gort-Freitas, N. A., Lin, Y., Bill, R., Siwicki, M., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0326 · Cited by 48
Alfaro, C., Suárez, N., Martínez‐Forero, I., Palazón, A., Rouzaut, A., Solano, S., Feijoó, E., Gúrpide, A., Bolaños, E., Erro, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017922 · Cited by 50
“DC migration from inflamed/infected [9] or malignant tissues [10,11] is important for the orchestration of immune responses.”
BackgroundIntestinal Dendritic Cells and Epithelial Barrier Dysfunction in Crohnʼs Disease
Silva, M. A. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20660 · Cited by 48
Zhao, P., Li, X., Yang, M., Shao, Q., Wang, D., Liu, S., Song, H., Song, B., Zhang, Y., & Qu, X. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2007.12.002 · Cited by 48
Sugaya, M., Fang, L., Cardones, A. R., Kakinuma, T., Jaber, S. H., Blauvelt, A., & Hwang, S. T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7665 · Cited by 47
“Although treating skin with TNF- enhanced both CCL21 staining in lymphatic vessels in skin as well as DC emigration, it was not shown that TNF- acted directly on LEC (10).”
BackgroundInfluentialCellular Immunotherapy of Cancer
Okur, F. V., & Brenner, M. K. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-786-0_19 · Cited by 48
Zhou, Y., Ye, T., Ye, C., Wan, C., Yuan, S., Liu, Y., Li, T., Jiang, F., Lovell, J. F., Jin, H., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.07.019 · Cited by 45
“Dendritic cells (DCs), as the most important APCs, are critical for cross-presenting tumor antigens and providing co-stimulatory signals to T cells [8,9].”
BackgroundCCL19-IgG Prevents Allograft Rejection by Impairment of Immune Cell Trafficking
Ziegler, E., Gueler, F., Rong, S., Mengel, M., Witzke, O., Kribben, A., Haller, H. G., Kunzendorf, U., & Krautwald, S. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005070782 · Cited by 47
“Third, cellular congestion in draining LN is markedly suppressed (29).”
BackgroundGomes, A. C., Flace, A., Saudan, P., Zabel, F., Cabral‐Miranda, G., El-Turabi, A., Manolova, V., & Bachmann, M. F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00226 · Cited by 45
Wang, J., Wang, S., Ye, T., Li, F., Gao, X., Wang, Y., Ye, P., Qing, S., Wang, C., Yue, H., et al. (2020) · Advanced Science · doi:10.1002/advs.202001108 · Cited by 46
Guazzone, V. A., Hollwegs, S., Mardirosian, M. N., Jacobo, P. V., Hackstein, H., Wygrecka, M., Schneider, E., Meinhardt, A., Lustig, L., & Fijak, M. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2010.01082.x · Cited by 50
Kobayashi, H., Miura, S., Nagata, H., Tsuzuki, Y., Hokari, R., Ogino, T., Watanabe, C., Azuma, T., & Ishii, H. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603250 · Cited by 45
“[46] recently showed that CCR7 / DCs subcutaneously injected into the mouse foodpad failed to migrate to the draining LNs.”
BackgroundAdvances and challenges: dendritic cell vaccination strategies for glioblastoma
Schaller, T. H., & Sampson, J. H. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1218762 · Cited by 45
“By preconditioning injection sites with inflammatory molecule TNF-α, researchers have previously shown improvements in DC lymph node homing in mice [81].”
MethodKeselowsky, B. G., Xia, C. Q., & Clare-Salzler, M. J. (2011) · Human Vaccines · doi:10.4161/hv.7.1.12916 · Cited by 44
Toll-Like Receptor 9 Agonists for Cancer Therapy
Melisi, D., Frizziero, M., Tamburrino, A., Zanotto, M., Carbone, C., Piro, G., & Tortora, G. (2014) · Biomedicines · doi:10.3390/biomedicines2030211 · Cited by 44
“Thus, pDCs are able to migrate from the peripheral tissue to the draining lymph node [41].”
BackgroundCobaleda‐Siles, M., Henriksen‐Lacey, M., Ruiz‐de‐Angulo, A., Bernecker, A., Gómez‐Vallejo, V., Szczupak, B., Llop, J., Pastor, G., Plaza‐García, S., Jauregui-Osoro, M., et al. (2014) · Small · doi:10.1002/smll.201401353 · Cited by 44
Dendritic Cell Interactions with Lymphatic Endothelium
Russo, E., Nitschké, M., & Halin, C. (2013) · Lymphatic Research and Biology · doi:10.1089/lrb.2013.0008 · Cited by 41
“This suggests that increased availability of CCL21 could contribute to the enhancement of DC migration that is typically observed in the context of inflammation.(66,68) However, it is still unclear how inflammation affects the in vivo secretion of CCL21 in LECs and the formation of the extracellular CCL21 gradient.”
BackgroundIn Vivo Tracking of Dendritic Cells in Patients With Multiple Myeloma
Prince, H. M., Wall, D. M., Ritchie, D., Hönemann, D., Harrison, S. J., Quach, H., Thompson, M., Hicks, R. J., Lau, E. W. F., Davison, J., et al. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31815c5153 · Cited by 43
Robinson, R., Khader, S. A., Locksley, R. M., Lien, E., Smiley, S. T., & Cooper, A. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5560 · Cited by 47
Immune cell trafficking to the islets during type 1 diabetes
Sandor, A., Jacobelli, J., & Friedman, R. S. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13353 · Cited by 48
Ramachandran, M., Jin, C., Yu, D., Eriksson, F., & Essand, M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400339 · Cited by 42
“However, it is claimed that CCR7 expression is necessary for efficient homing of Ag-bearing mDCs specifically to the T cell zones in the lymphatic system, even though other receptors are involved in unspecific guidance of DCs through the lymphatics (47).”
BackgroundAdjuvant effect of a natural TLR4 ligand on dendritic cell-based cancer immunotherapy
Kim, J. Y., Kim, Y. J., Kim, J. S., Ryu, H. S., Lee, H. K., Kang, J. S., Kim, H. M., Hong, J. T., Kim, Y. S., & Han, S. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.009 · Cited by 42
“CCL19 and CCL21, ligands of CCR7, are produced by lymphatic endothelial cells or stroma cells in lymph nodes and guide the emigration of DCs out of tissues and the immigration of DCs into draining lymph nodes [33].”
BackgroundLateef, Z., Baird, M. A., Wise, L. M., Young, S. L., Mercer, A. A., & Fleming, S. B. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01425.x · Cited by 46
“CCL19 is produced exclusively within the lymph node and directs DC to T-cell zones, whereas CCL21 is produced from the afferent lymphatic ducts and T-cell zones within the lymph node (Martin-fontecha et al., 2003; Alvarez et al., 2008).”
BackgroundGaray, J., D’Angelo, J. A., Park, Y., Summa, C. M., Aiken, M. L., Morales, E., Badizadegan, K., Fiebiger, E., & Dickinson, B. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903066 · Cited by 45
Huck, S. P., Tang, S., Andrew, K. A., Yang, J., Harper, J. L., & Ronchese, F. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0350-z · Cited by 45
In Vivo Cellular MRI of Dendritic Cell Migration Using Micrometer-Sized Iron Oxide (MPIO) Particles
Rohani, R., de Chickera, S. N., Willert, C., Chen, Y., Dekaban, G. A., & Foster, P. J. (2010) · Molecular Imaging and Biology · doi:10.1007/s11307-010-0403-0 · Cited by 41
“The relationship between the numbers of DCs injected and the increase in node cellularity is, however, not linear [ 8 ].”
BackgroundInfluentialLymph Node Hypertrophy following Leishmania major Infection Is Dependent on TLR9
Carvalho, L. P., Petritus, P. M., Trochtenberg, A., Zaph, C., Hill, D. A., Artis, D., & Scott, P. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101018 · Cited by 45
“CCR7 expression plays an important role in facilitating the migration of cells to the dLN (2, 20, 37).”
BackgroundInfluentialSynergy‐inducing chemokines enhance CCR2 ligand activities on monocytes
Kuscher, K., Danelon, G., Paoletti, S., Stefano, L., Schiraldi, M., Petkovic, V., Locati, M., Gerber, B. O., & Uguccioni, M. (2009) · European Journal of Immunology · doi:10.1002/eji.200838906 · Cited by 41
Self-citationIDO inhibits T-cell function through suppressing Vav1 expression and activation
Li, R., Wei, F., Yu, J., Li, H., Ren, X., & Ren, X. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.14.8882 · Cited by 44
Encabo, A., Solves, P., Carbonell‐Uberos, F., & Miñana, M. D. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01103.x · Cited by 41
Bollampalli, V. P., Yamashiro, L. H., Feng, X., Bierschenk, D., Gao, Y., Blom, H., Henriques‐Normark, B., Nylén, S., & Rothfuchs, A. G. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005206 · Cited by 43
“Indeed, TNF-α can condition a vaccination site and enhance T-cell priming [29].”
BackgroundInfluentialInitial Afferent Lymphatic Vessels Controlling Outbound Leukocyte Traffic from Skin to Lymph Nodes
Teijeira, Á., Rouzaut, A., & Melero, I. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00433 · Cited by 43
Obermajer, N., Urban, J. A., Wieckowski, E. U., Muthuswamy, R., Ravindranathan, R., Bartlett, D. L., & Kaliński, P. (2018) · Nature Protocols · doi:10.1038/nprot.2017.130 · Cited by 41
A Perspective on Nanoparticle Universal Influenza Vaccines
Deng, L., & Wang, B. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00206 · Cited by 40
Simmons, S., Sasaki, N., Umemoto, E., Uchida, Y., Fukuhara, S., Kitazawa, Y., Okudaira, M., Inoue, A., Tohya, K., Aoi, K., et al. (2019) · eLife · doi:10.7554/elife.41239 · Cited by 40
“CCR7 and its ligand CCL21 are essentially involved in the extravasation of T- and B-cells through lymph node HEVs and in the homing of various subpopulations of mature antigen-presenting DCs through afferent lymphatics to the lymph nodes (MartIn-Fontecha et al., 2003; Ohl et al., 2004).”
BackgroundChatzopoulos, K., Kotoula, V., Manoussou, K., Markou, K. D., Vlachtsis, K. C., Angouridakis, N., Nikolaou, A. C., Vassilakopoulou, M., Psyrri, A. K., & Fountzilas, G. (2019) · Head and Neck Pathology · doi:10.1007/s12105-019-01101-6 · Cited by 45
CXCR4 signaling controls dendritic cell location and activation at steady state and in inflammation
Gallego, C., Vétillard, M., Calmette, J., Roriz, M., Marin‐Esteban, V., Evrard, M., Aknin, M.-L. R., Pionnier, N. P., Lefrançois, M., Mercier‐Nomé, F., et al. (2021) · Blood · doi:10.1182/blood.2020006675 · Cited by 41
In Sickness and in Health: The Immunological Roles of the Lymphatic System
Johnson, L. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094458 · Cited by 46
“CCL21 is expressed constitutively by LECs [74,75], secreted, and immobilized to heparan sulphates, thus forming a steeply decaying perilymphatic gradient which guides CCR7+ DCs towards lymphatic capillaries from distances of up to 90 μm [68].”
BackgroundLymphatic Vessels in the Development of Tissue and Organ Rejection
Hos, D., & Cursiefen, C. (2013) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-7091-1646-3_10 · Cited by 40
Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the Spotlights
Fransen, M. F., van Hall, T., & OSSENDORP, F. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179401 · Cited by 45
“Local inflammation leads to lymph node swelling (also termed lymph node hypertrophy, reactive lymph node or lymph node shut down), which is a well-known reaction to immune activation, and has been described to be dependent on S1P1, TNF, IFN α / β and CD69 [13–16].”
BackgroundNayyar, A., Dawicki, W., Huang, H., Lu, M., Zhang, X., & Gordon, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103286 · Cited by 39
“, in the footpad) efficiently migrate to the draining lymph nodes of mice and there trigger immune responses, whereas CCR7(2) DCs do not do so efficiently (41).”
BackgroundLorenz, N., Loef, E. J., Kelch, I. D., Verdon, D. J., Black, M. M., Middleditch, M. J., Greenwood, D. R., Graham, E. S., Brooks, A. E., Dunbar, P. R., et al. (2016) · Immunology & Cell Biology · doi:10.1038/icb.2016.56 · Cited by 38
Lee, S. B., Lee, H., Lee, H.-J., Jeon, Y. H., Lee, S., Ahn, B., Lee, J., & Jeong, S. Y. (2017) · EJNMMI Research · doi:10.1186/s13550-017-0280-5 · Cited by 38
Oh, J., Wu, N., Barczak, A. J., Barbeau, R., Erle, D. J., & Shin, J. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700768 · Cited by 39
“The homeostatic DC maturation occurring at steady state in the periphery is also accompanied by CCR7 upregulation and associated with their migration to LNs (21).”
BackgroundInfluentialAfferent Lymphatic Transport and Peripheral Tissue Immunity
Steele, M. M., & Lund, A. W. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001060 · Cited by 41
“inflammatory cytokines, such as TNF-a (53, 54), and in-”
BackgroundBlocking Development of a CD8+ T Cell Response by Targeting Lymphatic Recruitment of APC
Teoh, D., Johnson, L. A., Hanke, T., McMichael, A. J., & Jackson, D. G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803661 · Cited by 39
Dendritic cell entry to lymphatic capillaries is orchestrated by CD44 and the hyaluronan glycocalyx
Johnson, L. A., Banerji, S., Lagerholm, B. C., & Jackson, D. G. (2021) · Life Science Alliance · doi:10.26508/lsa.202000908 · Cited by 37
Application of a Systems Biology Approach to Skin Allergy Risk Assessment
Maxwell, G., & Mackay, C. D. A. (2008) · Alternatives to Laboratory Animals · doi:10.1177/026119290803600510 · Cited by 38
Ma, Y., Poisson, L., Sánchez‐Schmitz, G., Pawar, S., Qu, C., Randolph, G. J., Warren, W. L., Mishkin, E. M., & Higbee, R. G. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03237.x · Cited by 37
Kitawaki, T., Kadowaki, N., Fukunaga, K., Kasai, Y., Maekawa, T., Ohmori, K., Itoh, T., Shimizu, A., Kuzushima, K., Kondo, T., et al. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.01.001 · Cited by 39
“Inflammation in the skin before DC injection facilitates DC migration to draining lymph nodes, leading to a stronger immune response [18,19].”
BackgroundMagnetic nanoparticles for imaging dendritic cells
Kobukai, S., Baheza, R. A., Cobb, J. G., Virostko, J. M., Xie, J., Gillman, A. R., Koktysh, D. S., Kerns, D., Does, M. D., Gore, J. C., et al. (2010) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22313 · Cited by 37
Schimmelpfennig, C., Schulz, S., Arber, C., Baker, J. B., Tarner, I. H., McBride, J., Contag, C. H., & Negrin, R. S. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61219-9 · Cited by 37
Engineering DNA Nanostructures to Manipulate Immune Receptor Signaling and Immune Cell Fates
Tseng, C., Wang, W. X., Douglas, T. R., & Chou, L. Y. T. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101844 · Cited by 39
TRP Ion Channels in Immune Cells and Their Implications for Inflammation
Yan, Q., Gao, C., Li, M., Lan, R., Wei, S., Fan, R., & Cheng, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052719 · Cited by 44
Regulation of Lymph Node Vascular–Stromal Compartment by Dendritic Cells
Dasoveanu, D., Shipman, W. D., Chia, D. J., Chyou, S., & Lu, T. T. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.08.013 · Cited by 41
“Footpad injection of cultured mature or immature BMDCs resulted in the accumulation of the injected DCs in the draining node and lymph node enlargement by 1 day, suggesting that endogenous migratory DCs could induce lymph node enlargement [37,60].”
BackgroundZafar, S., Parviainen, S., Siurala, M., Hemminki, O., Havunen, R., Tähtinen, S., Bramante, S., Vassilev, L., Wang, H., Lieber, A., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1265717 · Cited by 35
“TNF-a is a proinflammatory cytokine known to enhance the migration of DCs to lymph nodes.(55) Our data are in accordance with this notion, as we saw enhanced production of TNF-a in virus injected tumors in conjunction with increased migration of DCs to lymph nodes.”
ResultImmune response in glioma’s microenvironment
Chen, H., Li, M., Guo, Y., Zhong, Y., He, Z., Xu, Y., & Zou, J. (2020) · Innovative Surgical Sciences · doi:10.1515/iss-2019-0001 · Cited by 38
“TGF-B activates the Ras protein pathway and MAPK pathway to furthermediate the proliferation of highgrade glioma cells and up-regulate the expression of vascular endothelial growth factor (VEGF) and its downstream receptors [62, 63].”
BackgroundGevaert, J. J., Fink, C., Dikeakos, J. D., Dekaban, G. A., & Foster, P. J. (2022) · Molecular Imaging and Biology · doi:10.1007/s11307-022-01738-w · Cited by 37
Mueller, M., Schlosser, E., Gander, B. A., & Groettrup, M. (2011) · International Journal of Cancer · doi:10.1002/ijc.25914 · Cited by 35
Dendritic Cells Take up and Present Antigens from Viable and Apoptotic Polymorphonuclear Leukocytes
Alfaro, C., Suarez, N., Oñate, C., Perez-Gracia, J. L., Martinez-Forero, I., Hervas-Stubbs, S., Rodriguez, I., Perez, G., Bolaños, E., Palazon, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029300 · Cited by 32
“Maturation means migration towards lymphoid organs triggered by CCR7 ligands [19], upregulation of co-stimulatory molecules for T cells and production of T-cell stimulating cytokines [17].”
BackgroundEpigenetic Control of Ccr7 Expression in Distinct Lineages of Lung Dendritic Cells
Moran, T. P., Nakano, H., Kondilis-Mangum, H. D., Wade, P. A., & Cook, D. N. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401104 · Cited by 37
“Because LN homing by DCs is considered necessary for optimal stimulation of Ag-specific T cells (45), understanding how GM-CSF and FL influence the”
BackgroundMiles, B., Zakhary, I., El-Awady, A., Scisci, E., Carrion, J., O'Neill, J. C., Rawlings, A., Stern, J. K., Susin, C., & Cutler, C. W. (2014) · Infection and Immunity · doi:10.1128/iai.01157-13 · Cited by 32
Flt3L Dependence Helps Define an Uncharacterized Subset of Murine Cutaneous Dendritic Cells
Mollah, S. A., Dobrin, J. S., Feder, R. E., Tse, S., de Matos, I. G., Cheong, C., Steinman, R. M., & Anandasabapathy, N. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.515 · Cited by 35
“CCR7−/− mice were bred at Rockefeller after purchase from Jackson and are described with respect to defects in the skin-derived DC migration (Martin-Fontecha et al., 2008; Martin-Fontecha et al., 2003).”
MethodNon-invasive imaging of dendritic cell migration in vivo
Baumjohann, D., & Lutz, M. B. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.011 · Cited by 40
Early Interaction of Yersinia pestis with APCs in the Lung
Bosio, C. M., Goodyear, A., & DOW, S. W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6750 · Cited by 35
“Up-regulation of CCR7 is typically attributed to dendritic cells undergoing maturation and enables their movement to the draining lymph nodes (21, 22).”
BackgroundIsolation of Murine Lymph Node Stromal Cells
Broggi, M. A. S., Schmaler, M., Lagarde, N., & Rossi, S. W. (2014) · Journal of Visualized Experiments · doi:10.3791/51803 · Cited by 43
Regulation of the Migration of Distinct Dendritic Cell Subsets
Feng, M., Zhou, S., Yu, Y., Su, Q., Li, X., & Lin, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.635221 · Cited by 40
Metadata
- Authors
- Martín-Fontecha, A., Sebastiani, S., Höpken, U. E., Uguccioni, M., Lipp, M., Lanzavecchia, A., & Sallusto, F.
- Affiliations
- 1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
- Institute for Research in Biomedicine (CH)
- 2Max Delbrück Center for Molecular Medicine, 13122 Berlin-Buch, Germany
- Max Delbrück Center (DE)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-08-18
- Volume
- 198
- Issue
- 4
- Pages
- 615-621
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2194169
- OpenAlex
- W2149057253
- Cited by
- 878
- References
- 29
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 16 · 2023: 24 · 2022: 15 · 2021: 28 · 2020: 27 · 2019: 31 · 2018: 33 · 2017: 37 · 2016: 39 · 2015: 28 · 2014: 29 · 2013: 57 · 2012: 30
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Science Foundation
- Institute for Research in Biomedicine
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (63885)
- Helmut Horten Stiftung
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- dendritic cell migration, draining lymph nodes, CCR7, CCL21, lymphatic endothelial cells, inflammatory cytokines, TNF-α, CD4+ T cell responses, antigen-pulsed dendritic cells, dendritic cell vaccine, lymph node cellularity, tissue inflammation
- MeSH terms
- Animals, Cell Movement, Dendritic Cells, Fluorescent Dyes, Humans, Interleukin-1, Lymph Nodes, Mice, Inbred BALB C, T-Lymphocytes, Tumor Necrosis Factor-alpha, Cell Transplantation, Receptors, Chemokine, Mice, Receptors, CCR7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.